Skip to content
naulon
Not checkedNot checked for notices yet.

Enhanced Expression of Radiation-induced Leukocyte in Multiple Primary Breast Cancer Patients: Potential New Marker of cancer susceptibility

Masato Mitsuhashi, David Peel, Argyrios Ziogas and 1 more

Biomarker Insights · 2009

doi:10.4137/bmi.s3774 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

This study was designed to discover blood biomarkers of cancer susceptibility using invasive multiple (n = 21), single primary breast cancer (n = 21), and control subjects (n = 20). Heparinized whole blood was incubated at 37 °C for 2 hours after 0–10 Gy of radiation, then cell cycle arrest marker CDKN1A and apoptosis marker BBC3 mRNA were quantified. This epidemiological study was practically feasible because radiation-induced mRNA was preserved for at least 1 day whenever blood was stored at 4 °C (r 2 = 0.901). Moreover, blood could be stored frozen after radiation treatment (r 2 = 0.797). Radiation- induced CDKN1A and BBC3 mRNA were dose dependent, and the degree of induction of CDKN1A was correlated with that of BBC3 (r 2 = 0.679). Interestingly, multiple primary cases showed higher induction of CDKN1A mRNA than single primary and control groups, whereas BBC3 did not show such differences. The results suggested that cancer susceptibility represented by the multiple primary breast cancer cases was related to over-reaction of CDKN1A mRNA, not BBC3. The study also suggests that ex vivo gene expression analysis could potentially be used as a new tool in epidemiological studies for cancer and radiation sensitivity research.

Abstract licence: CC BY-NC

References22

    22 more references, whose wording the paper’s licence keeps private.

    Reads

    Read by people on this page

    None yet.

    Checked or read by AI through naulon

    None yet.

    A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

    Are you an author?

    Is this your paper?

    Claim it to add your note and be paid when agents cite it. Free.